Biotech Firm Is Moving From Park Slope To Industry City

Industry City tenants are known for their innovativeness, although most often in the tech, art, food, sports, and crafting/furniture spaces. Now, add biotech to the list.

Suneris, a biotech startup focused on developing a blood-clotting gel, has leased approximately 10,000 square feet of space in the industrial hub along the Sunset Park waterfront and plans to move from their current Park Slope home (of a comparatively mere 2,500 square feet) in this summer, as reported by Crain’s. They also may soon double that space with an additional 15,000 square feet.

What’s blood-clotting gel and how is it useful?

Its new space will house office, lab and manufacturing facilities. Suneris plans to launch its product for use on animals by the end of the year and will then seek approval from the U.S. Food and Drug Administration to expand into the emergency medicine, military and surgical markets. The gel has the ability to stop profuse bleeding in under 10 seconds without any application of pressure.

“This new space will do two things for us. First, it will give us the capacity to serve the whole animal-health market, and on the other hand it will give us space where we can begin human product development as well,” said Joe Landolina, the company’s chief executive, adding that the firm is preparing to sell its product to veterinarians with hopes of future FDA approval.

Jobs will mostly remain with current employees and “a round of senior-level hires, primarily recruiting from New Jersey and Long Island.”